The huge prognostic difference between early and late stage hepatocellular carcinoma (HCC)
is a challenging diagnostic problem. Alpha-fetoprotein is the mostly widely used …

… of HCC screening and provide practical guidance on patient selection and screening methods…
Hepatocellular carcinoma screening has been reported to be cost-effective in patients with …

… hepatocellular carcinoma (HCC). As HCC is associated with significant morbidity and mortality,
screening … In this review, we evaluate the literature on screening patients with CHB for …

… way to screen a population of patients at risk for hepatocellular carcinoma when (1) each
patient’s disease evolves stochastically and (2) there are limited screening resources shared …

Hepatocellular carcinoma (HCC) remains a major cause of cancer-related mortality worldwide.
Delayed diagnosis is a major factor responsible for the poor prognosis of HCC. Several …

… hepatocellular carcinoma (HCC) screening. MRI is accurate for the detection of HCC, but a
complete MRI is not feasible as a screening … diagnostic accuracy of AMRI for HCC screening. …

Hepatocellular carcinoma (HCC) mortality rates are increasing globally, and particularly in
the Western world. Cirrhosis remains the predominant risk factor for HCC. However, …

Background & Aims Hepatocellular carcinoma (HCC) screening of patients with cirrhosis is
recommended by professional societies to increase detection of early stage tumors and …

… Hepatocellular carcinoma (HCC) is the sixth most … HCC screening continuum including
underrecognition of at-risk individuals, underuse of HCC screening, and suboptimal screening …

Hepatocellular carcinoma (HCC) makes up 75%-85% of all primary liver cancers and is the
fourth most common cause of cancer related death worldwide. Chronic liver disease is the …